Global biomedical companies are welcome to step up cooperation with China, Vice President Han Zheng said in Beijing on Wednesday when meeting with Helge Lund, chair of Novo Nordisk board of directors from Denmark.
Han recalled that President Xi Jinping replied in May to a letter from the founder of the Danish Chamber of Commerce in China, encouraging the chamber and its member enterprises to make new contributions to enhancing China-Denmark and China-Europe friendship and deepening mutually beneficial cooperation.
The economic complementarity between China and Denmark, and China and Europe, is strong, with broad prospects for cooperation, Han said.
He noted that by continuously deepening its reform and expanding its high-level opening-up, China will provide huge development opportunities for enterprises from all over the world, including Novo Nordisk.
China prioritizes its people's health, Han said, stressing that the country has built the world's largest basic health care insurance network and its average life expectancy continues to rise. He welcomed Novo Nordisk and other leading biomedical companies to step up cooperation with China.
Lund spoke highly of the achievements China has made in economic and social development in recent years, stating that the company will cultivate the Chinese market further, expand investment in China and achieve win-win results.
Chinese VP meets Danish biomedical company chair
